DOI QR코드

DOI QR Code

Synthesis, Cytotoxicity and Topoisomerase II Inhibition Study of New Thioxanthone Analogues

  • Woo, Sang-Wook (College of Pharmacy, Catholic University of Daegu) ;
  • Kang, Da-Hye (Division of Life & Pharmaceutical Sciences, Ewha Womans University) ;
  • Kim, Jung-Sook (College of Pharmacy, Catholic University of Daegu) ;
  • Lee, Chong-Soon (Department of Biochemistry, College of Natural Sciences, Yeungnam University) ;
  • Lee, Eung-Seok (College of Pharmacy, Yeungnam University) ;
  • Jahng, Yurng-Dong (College of Pharmacy, Yeungnam University) ;
  • Kwon, Young-Joo (Division of Life & Pharmaceutical Sciences, Ewha Womans University) ;
  • Na, Young-Hwa (College of Pharmacy, Catholic University of Daegu)
  • Published : 2008.02.20

Abstract

Keywords

References

  1. Pinto, M. M. M.; Sousa, M. E.; Nascimento, M. S. J. Curr. Med. Chem. 2005, 12, 2517 https://doi.org/10.2174/092986705774370691
  2. Peres, V.; Nagem, T. J.; de Oliveira, F. F. Phytochemistry 2000, 55, 683 https://doi.org/10.1016/S0031-9422(00)00303-4
  3. Wang, L.-W.; Kang, J.-J.; Chen, I.-J.; Teng, C.-M.; Lin, C.-N. Bioorg. Med. Chem. 2002, 10, 567 https://doi.org/10.1016/S0968-0896(01)00315-7
  4. Lin, C.-N.; Liou, S.-S.; Ko, F.-N.; Teng, C.-M. J. Pharm. Sci. 1992, 81, 1109 https://doi.org/10.1002/jps.2600811114
  5. Lin, C.-N.; Liou, S.-S.; Ko, F.-N.; Teng, C.-M. J. Pharm. Sci. 1993, 82, 11 https://doi.org/10.1002/jps.2600820103
  6. Liou, S.-S.; Shieh, W.-L.; Cheng, T.-H.; Won, S.-J.; Lin, C.-N. J. Pharm. Pharmacol. 1993, 45, 791 https://doi.org/10.1111/j.2042-7158.1993.tb05686.x
  7. Lin, C.-N.; Liou, S.-S.; Lee, T.-H.; Chuang, Y.-C.; Won, S.-J. J. Pharm. Pharmacol. 1996, 48, 539 https://doi.org/10.1111/j.2042-7158.1996.tb05970.x
  8. Pedro, M.; Cerqueira, F.; Sousa, M. E.; Nascimento, M. S. J.; Pinto, M. Bioorg. Med. Chem. 2002, 10, 3725 https://doi.org/10.1016/S0968-0896(02)00379-6
  9. Saraiva, L.; Fresco, P.; Pinto, E.; Sousa, E.; Pinto, M.; Goncalves, J. Bioorg. Med. Chem. 2003, 11, 1215 https://doi.org/10.1016/S0968-0896(02)00641-7
  10. Zhou, Y.-S.; Hou, A.-J.; Zhu, G.-F.; Chen, Y.-F.; Sun, H.-D.; Zhao, Q.-S. Bioorg. Med. Chem. 2004, 12, 1947 https://doi.org/10.1016/j.bmc.2004.01.030
  11. Kupchan, S. M.; Streelman, D. R.; Sneden, A. T. J. Nat. Prod. 1980, 43, 296 https://doi.org/10.1021/np50008a010
  12. Cassady, J. M. J. Nat. Prod. 1990, 53, 23 https://doi.org/10.1021/np50067a003
  13. Hansen, M.; Lee, S.-J.; Cassady, J. M.; Hurley, L. H. J. Am. Chem. Soc. 1996, 118, 5553 https://doi.org/10.1021/ja960319c
  14. Kwok, Y.; Hurley, L. H. J. Biol. Chem. 1998, 273, 33020 https://doi.org/10.1074/jbc.273.49.33020
  15. Forterre, P.; Gribaldo, S.; Gadelle, D.; Serre, M. C. Biochimie. 2007, 89, 427 https://doi.org/10.1016/j.biochi.2006.12.009
  16. Schvartzman, J. B.; Stasiak, A. EMBO 2004, 5, 256 https://doi.org/10.1038/sj.embor.7400101
  17. Holden, J. A. Curr Med Chem Anticancer Agents 2001, 1, 1 https://doi.org/10.2174/1568011013354859
  18. Woo, S.; Jung, J.; Lee, C.; Kwon, Y.; Na, Y. Bioorg. Med. Chem. Lett. 2007, 17, 1163 https://doi.org/10.1016/j.bmcl.2006.12.030
  19. Kostakis, I. K.; Magiatis, P.; Pouli, N.; Marakos, P.; Skaltsounis, A.-L.; Pratsinis, H.; Leonce, S.; Pierre, A. J. Med. Chem. 2002, 45, 2599 https://doi.org/10.1021/jm011117g
  20. Kostakis, I. K.; Ghirtis, K.; Pouli, N.; Marakos, P.; Skaltsounis, A.-L.; Leonce, S.; Caignard, D. H.; Atassi, G. IL Farmaco 2000, 55, 455 https://doi.org/10.1016/S0014-827X(00)00068-9
  21. Kostakis, I. K.; Magiatis, P.; Pouli, N.; Marakos, P.; Mikros, E.; Skaltsounis, A.-L.; Leonce, S.; Atassi, G.; Renard, P. Bioorg. Med. Chem. 2001, 9, 2793 https://doi.org/10.1016/S0968-0896(01)00130-4

Cited by

  1. Recent cancer drug development with xanthone structures vol.61, pp.6, 2010, https://doi.org/10.1211/jpp.61.06.0002
  2. Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies vol.23, pp.3, 2018, https://doi.org/10.3390/molecules23030626
  3. ChemInform Abstract: Synthesis, Cytotoxicity and Topoisomerase II Inhibition Study of New Thioxanthone Analogues. vol.39, pp.28, 2008, https://doi.org/10.1002/chin.200828130
  4. Recent cancer drug development with xanthone structures. vol.61, pp.6, 2008, https://doi.org/10.1211/jpp/61.06.0002
  5. Design, Synthesis, Antitumor Activity and Mode of Action of Novel Oxiranyl and Thiiranyl Phenol Derivatives vol.30, pp.7, 2008, https://doi.org/10.5012/bkcs.2009.30.7.1463
  6. Antibacterial Activity and Synergism of the Hybrid Antimicrobial Peptide, CAMA-syn vol.30, pp.8, 2008, https://doi.org/10.5012/bkcs.2009.30.8.1839
  7. Ruthenium-catalyzed C–H activation of thioxanthones vol.11, pp.None, 2008, https://doi.org/10.3762/bjoc.11.49
  8. Xanthones as P-glycoprotein modulators and their impact on drug bioavailability vol.17, pp.4, 2008, https://doi.org/10.1080/17425255.2021.1861247